US 7,491,706 B2
	Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof
Yongli Yu, Changchun (China); and Liying Wang, Changchun (China)
Assigned to Changchun Huapu Biotechnology Co., Ltd., Changchun, Jilin (China)
Appl. No. 10/565,718 PCT Filed Jul. 26, 2004, PCT No. PCT/CN2004/000863 § 371(c)(1), (2), (4) Date Aug. 28, 2006, PCT Pub. No. WO2005/014611, PCT Pub. Date Feb. 17, 2005.
Claims priority of application No. 03 1 46157 (CN), filed on Jul. 25, 2003; and application No. 03 1 56224 (CN), filed on Sep. 05, 2003.
Prior Publication US 2007/0155683 A1, Jul. 05, 2007
Int. Cl. A01N 43/04 (2006.01); A01N 37/18 (2006.01)

U.S. Cl. 514—44  [514/2; 424/180.1; 424/185.1; 424/192.1; 424/193.1; 435/91.1; 435/91.5; 536/23.1; 536/23.4; 536/23.5; 536/23.52; 536/25.3]

14 Claims

1. An artificial CpG-containing single-stranded oligodeoxynucleotide, which consists of a single-stranded oligonucleotide DNA molecule containing one or more CpG(s) which has a sequence as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or SEQ ID NO: 5.